| Abstract P237 – Table 1. HIV indicator condition HIV testing rates, grouped by sexually transmitted infections and non‐sexually transmitted infections. | |||||
|---|---|---|---|---|---|
| Reported, n (%) | Test offereda, n (%) | Test performeda, n (%) | p‐valueb | ||
| Total (n, %) | 377 (100) | 118 (31.3) | 97 (25.7) | <0.001 | |
| Sexually transmitted infections | 238 (63.1) | 91 (38.2) | 72 (30.2) | <0.001 | |
| Non‐sexually transmitted infections | (All other HIV indicator conditions) | 139 (36.9) | 27 (19.4) | 25 (18.0) | <0.001 |
| Cervical dysplasia | 4 (1.1) | 0 (0.0) | 0 (0.0) | ||
| Community‐acquired pneumonia | 25 (6.6) | 0 (0.0) | 0 (0.0) | ||
| Herpes zoster | 47 (12.5) | 4 (8.5) | 3 (6.4) | ||
| Mononucleosis‐like illness | 2 (0.5) | 1 (50.0) | 1 (50.0) | ||
| Seborrhoeic dermatitis/exanthema | 9 (2.4) | 4 (44.4) | 3 (33.3) | ||
| Severe or atypical psoriasis | 4 (1.1) | 1 (25.0) | 1 (25.0) | ||
| Unexplained chronic diarrhoea | 3 (0.8) | 0 (0.0) | 0 (0.0) | ||
| Unexplained fever | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
| Unexplained leukocytopenia | 4 (1.1) | 1 (25.0) | 1 (25.0) | ||
| Unexplained lymphadenopathy | 8 (2.1) | 3 (37.5) | 3 (37.5) | ||
| Unexplained oral candidiasis | 13 (3.4) | 3 (23.1) | 3 (23.1) | ||
| Unexplained thrombocytopenia | 2 (0.5) | 0 (0.0) | 0 (0.0) | ||
| Unexplained weight loss | 18 (4.8) | 10 (55.6) | 10 (55.6) | ||
aPercentages calculated based on reported total of HIV indicator conditions;
bcalculation based on comparison between observed HIV test rate and the assumed baseline HIV test uptake of 50% (z‐test).